ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > CD138

CD138

概要

Name:Syndecan-1
Target Synonym:Syndecan Proteoglycan 1,CD138 Antigen,SYND1,SDC,Heparan Sulfate Proteoglycan Fibroblast Growth Factor Receptor,Syndecan,CD138,Syndecan-1,SDC1,Syndecan 1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 2 Clinical

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
HGS-S253 Mouse Recombinant Monoclonal Anti-CD138 Antibody, Mouse (5G4)
ACRO Quality

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
CART-138 (Chinese PLA General Hospital) Phase 2 Clinical Pla General Hospital Liver Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Brain Neoplasms; Colorectal Neoplasms Details
ATLCAR.CD138 (UNC Lineberger Comprehensive Cancer Center) Phase 1 Clinical Unc Lineberger Comprehensive Cancer Center Multiple Myeloma; Immune System Diseases Details

This web search service is supported by Google Inc.

totopphone